FSS Receives IDE Approval For FlexStent Femoropopliteal
Flexible Stenting Solutions (FSS) has received Conditional Investigational Device Exemption (IDE) approval for its FlexStent Femoropopliteal Self Expanding Stent System. FSS is now authorized to begin its US
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.